Search Ontology:
ChEBI
ilomastat
- Term ID
- CHEBI:137236
- Synonyms
-
- (2R)-N(4)-hydroxy-N(1)-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide
- CS 610
- galardin
- GM 6001
- GM-6001
- GM6001
- ilomastat
- Definition
- An N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor
- References
-
- cas:142880-36-2
- kegg.drug:D03793
- lincs.smallmolecule:LSM-3143
- pdb-ccd:GM6
- pubmed:12410973
- pubmed:14568001
- pubmed:15350544
- pubmed:16565079
- pubmed:16712832
- pubmed:18782669
- pubmed:18790756
- pubmed:18837084
- pubmed:19545667
- pubmed:20299089
- pubmed:20818082
- pubmed:21040999
- pubmed:21146503
- pubmed:22512086
- pubmed:22903888
- pubmed:23141517
- pubmed:23870824
- pubmed:24380772
- pubmed:24589605
- pubmed:25576979
- pubmed:26171681
- pubmed:26394037
- pubmed:27038494
- pubmed:27112177
- pubmed:27296149
- pubmed:27708133
- pubmed:27743382
- pubmed:28297575
- pubmed:28298987
- pubmed:28417261
- reaxys:7982373
- wikipedia.en:Ilomastat
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from ilomastat
Phenotype where environments contain ilomastat
Phenotype modified by environments containing ilomastat
Phenotype affecting ilomastat
Human Disease Model